Annual Drug Patent Expirations for PROMACTA
Promacta is a drug marketed by Novartis Pharms Corp and is included in two NDAs. It is available from two suppliers. There are fourteen patents protecting this drug and two Paragraph IV challenges.
Copyright © DrugPatentWatch. Originally published at Patent delisted for Novartis Pharms drug PROMACTA